ClinicalTrials.gg
RecruitingNCT07766265Updated Nov 10, 2026

NEST: A Group Intervention for Parents With Complex PTSD

An interventional study of Trauma-Informed Parenting Group Intervention in Complex Post-Traumatic Stress Disorder, sponsored by St.Gallen University of Applied Sciences. Recruiting at 3 sites in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by St.Gallen University of Applied Sciences · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Updated Nov 10, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this pilot clinical trial is to learn whether NEST, a new trauma-informed group therapy program, is feasible and acceptable for parents with Complex PTSD, a condition that can develop after prolonged or repeated traumatic experiences. Parenting can be especially challenging for people with this condition, and few treatment programs currently address this specific need. The main questions it aims to answer are:

  • Is the NEST group intervention feasible to deliver and acceptable to parents with Complex PTSD?
  • Do parents' trauma-related symptoms and their experience of the parenting role change from before to after the intervention?

Participants will:

  • Complete online questionnaires about trauma-related symptoms and parenting before the group therapy, after it ends, and again three months later
  • Take part in nine weekly 90-minute group therapy sessions, co-led by a member of the study team and a mental health professional from the treatment site
  • Some participants will additionally be invited to a short interview about their experience with the group therapy
Read the detailed description

NEST (Nurturing Emotional Safety in Trauma-Affected Parenting) is a single-arm, multicenter pilot feasibility and acceptability study of a newly developed, manualized trauma-informed parenting group intervention for parents with ICD-11 Complex Post-Traumatic Stress Disorder (CPTSD).

The 9-session group intervention addresses core parenting-related challenges associated with CPTSD, including self-concept and self-efficacy as a parent, emotion regulation within the parent-child relationship, setting boundaries, regulating closeness and distance in the parent-child relationship, and age-appropriate communication with children about the parent's diagnosis. Sessions are trauma-sensitive but not trauma-focused; traumatic memories themselves are not processed within the group. Each group is closed, comprises 6-8 participants, and is co-led by a member of the sponsor's (OST) study team together with a trained psychologist/psychotherapist affiliated with the respective treatment site.

The study is conducted at two clinical sites, the Psychiatric Services Aargau (PDAG) and the Integrated Psychiatry Winterthur (ipw). At each clinical site, the NEST group therapy forms part of participants' regular clinical care and is billed via mandatory health insurance; study-specific procedures are conducted separately by the OST study team. These study-specific procedures consist of self-report questionnaires completed by all participants and a semi-structured qualitative interview completed by a subset of participants after completing the group therapy, to explore their experience of the intervention in greater depth.

02

Conditions studied

  • Complex Post-Traumatic Stress Disorder

Keywords

  • Complex Post-Traumatic Stress Disorder
  • CPTSD
  • ICD-11
  • Trauma-Informed Intervention
  • Parents
  • Parenting Intervention
  • Group Therapy
03

In context

Stress Disorders, Post-Traumatic

2,682 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 601 are open to participants now.

This study's planned enrollment of 32 is below the median of 69 across 2,196 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

St.Gallen University of Applied Sciences is the lead sponsor of 6 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of CPTSD according to ICD-11, confirmed by the treating psychotherapist or psychiatrist
  • Caregiver of at least one child aged 0-18 years (including biological, adoptive, step-, or foster parents and other primary caregivers)
  • Currently receiving individual psychotherapeutic treatment (outpatient or inpatient setting)
  • Age 18 years or older
  • Sufficient German language proficiency to participate in group sessions and complete study questionnaires
  • Ability to provide written

Exclusion criteria

Exclusion Criteria:

  • Current acute psychosis or severe psychiatric instability requiring immediate intensive treatment
  • Severe cognitive impairment or inability to participate adequately in group-based procedures
  • No current contact with the child
  • Insufficient German language proficiency
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    NEST Group Intervention

    Participants receive the NEST group intervention, a manualized, trauma-informed program comprising nine weekly 90-minute group sessions co-led by a member of the study team and a mental health professional from the treatment site. Sessions address parenting-related challenges associated with Complex PTSD, including self-efficacy as a parent, emotion regulation within the parent-child relationship, setting boundaries, and age-appropriate communication with children about the parent's diagnosis. All participants complete self-report questionnaires at three time points (T0, T1, T2) and a subset also completes a semi-structured qualitative interview at T1.

    Behavioral: Trauma-Informed Parenting Group Intervention

Interventions

  • BehavioralTrauma-Informed Parenting Group Intervention

    The NEST group intervention is a manualized, trauma-informed program consisting of nine weekly 90-minute group sessions, co-led by a member of the study team and a mental health professional from the treatment site. Groups are closed and comprise 6-8 parents. Sessions address parenting-related challenges associated with Complex PTSD, including self-concept and self-efficacy as a parent, emotion regulation within the parent-child relationship, setting boundaries, regulating closeness and distance in the parent-child relationship, and age-appropriate communication with children about the parent's diagnosis. Sessions are trauma-sensitive but not trauma-focused; traumatic memories are not processed within the group.

    Also known as: NEST - Nurturing Emotional Safety in Trauma-Affected Parenting

06

What researchers measure

Primary outcomes

  1. Feasibility - Enrollment/ Recruitment Rate

    Feasibility will be assessed descriptively by the number of participants enrolled and the time required to reach the planned sample size.

    Time frame: From day one of recruitment to baseline measurement T0

  2. Feasibility - Retention Rate

    Retention will be assessed as the proportion of participants completing the post-intervention assessment (T1). A retention rate ≥70% at T1 is defined a priori as the benchmark for implementation-readiness.

    Time frame: From enrollment through T1 (approximately 9-10 weeks after enrollment)

  3. Feasibility - Intervention Adherence (Session Attendance)

    Adherence will be assessed as the proportion of participants attending at least 7 of 9 group sessions. A rate of ≥70% of participants attending at least 7 of 9 sessions is defined a priori as the benchmark for implementation-readiness.

    Time frame: From enrollment through completion of the 9-session group intervention (approximately 9-10 weeks after enrollment)

  4. Feasibility - Protocol Deviations

    Feasibility will be assessed descriptively through documentation of protocol deviations occurring during the intervention.

    Time frame: From enrollment through T1 (approximately 9-10 weeks after enrollment)

  5. Acceptability - TFA Questionnaire

    Acceptability will be assessed using the generic Theoretical Framework of Acceptability questionnaire (TFA; Sekhon et al., 2022), translated into German and adapted to the group therapy context. The TFA covers seven constructs (affective attitude, burden, ethicality, intervention coherence, opportunity costs, perceived effectiveness, self-efficacy) plus a general acceptability item. Acceptability is considered sufficient if ratings indicate an overall positive evaluation.

    Time frame: Post-intervention (T1, approximately 9-10 weeks after enrollment)

  6. Acceptability - Qualitative Interviews

    A subset of participants will additionally complete a semi-structured qualitative interview (approximately 40-50 minutes) exploring their experience of the intervention. Acceptability is considered sufficient if no substantial recurring concerns regarding safety, burden, or contextual fit emerge in qualitative findings.

    Time frame: Post-intervention (T1, approximately 9-10 weeks after enrollment)

Secondary outcomes

  1. ICD-11 PTSD and Complex PTSD Symptom Severity

    Assessed using the International Trauma Questionnaire with Clinical Checks (ITQ-CC; Shevlin et al., 2025; German version: Kratzer et al., 2025), which measures ICD-11 PTSD and Complex PTSD symptom severity, including disturbances in self-organisation. Changes in total and/or subscale scores across time points will be analysed descriptively and exploratively.

    Time frame: Baseline (T0), post-intervention (T1, approximately 9-10 weeks after enrollment), and 3-month follow-up (T2)

  2. Parental Stress (PSS)

    Assessed using the Parental Stress Scale (PSS; Berry \& Jones, 1995; German validation: Kölch et al., 2022), an 18-item measure of parenting-related stress across positive and negative dimensions of the parenting role. Changes in total and/or subscale scores across time points will be analysed descriptively and exploratively.

    Time frame: Baseline (T0), post-intervention (T1, approximately 9-10 weeks after enrollment), and 3-month follow-up (T2)

  3. Parental Self-Efficacy

    Assessed using the Brief Parental Self-Efficacy Scale (BPSES; Woolgar et al., 2025), a 5-item measure of parents' perceived competence and confidence in their parenting role. Changes in total score across time points will be analysed descriptively and exploratively.

    Time frame: Baseline (T0), post-intervention (T1, approximately 9-10 weeks after enrollment), and 3-month follow-up (T2)

  4. Parenting Practices

    Assessed using the Parenting Scale Short Form (PS-8; Kliem et al., 2018), an 8-item measure of dysfunctional discipline practices, comprising two subscales - laxness and overreactivity - developed and validated in a German representative population sample. Changes in total and/or subscale scores across time points will be analysed descriptively and exploratively.

    Time frame: Baseline (T0), post-intervention (T1, approximately 9-10 weeks after enrollment), and 3-month follow-up (T2)

  5. Parental Reflective Functioning

    Assessed using the Parental Reflective Functioning Questionnaire (PRFQ; Luyten et al., 2017; German validation: Wildner et al., 2024), a 16-item measure of parents' capacity to mentalise in relation to their child, across three subscales: certainty about mental states, interest and curiosity, and pre-mentalising modes. Changes in total and/or subscale scores across time points will be analysed descriptively and exploratively.

    Time frame: Baseline (T0), post-intervention (T1, approximately 9-10 weeks after enrollment), and 3-month follow-up (T2)

  6. Family Emotional Responsiveness

    Assessed using the Family Assessment Device - Affective Responsiveness subscale (FAD-AR; Miller et al., 1985; German validation: Beierlein et al., 2017), a 7-item subscale assessing the quality of emotional responsiveness within the family. Changes in score across time points will be analysed descriptively and exploratively.

    Time frame: Baseline (T0), post-intervention (T1, approximately 9-10 weeks after enrollment), and 3-month follow-up (T2)

07

Study locations

3 of 3 sites recruiting
  • Psychiatrische Dienste Aargau (PDAG)
    Windisch, Canton of Aargau 5210, Switzerland
    Recruiting
  • Eastern Switzerland University of Applied Sciences (OST)
    Sankt Gallen, Canton of St. Gallen 9001, Switzerland
    Recruiting
  • Integrierte Psychiatrie Winterthur (ipw)
    Winterthur, Canton of Zurich 8400, Switzerland
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — A data sharing plan has not yet been finalized. Quantitative outcome data will likely be made available to other researchers in de-identified form, in line with the Swiss National Science Foundation's Open Science requirements; the specific repository or platform has not yet been determined, though registration on the Open Science Framework (OSF) is planned. Sharing of qualitative interview data is expected to be more limited, given the sensitivity of the content and the increased risk of re-identification in a small qualitative sample. Further details will be specified once the data management and sharing plan has been finalized.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Not yet recruiting→Recruiting
changed Nov 10, 2026
Sites
3 sites changed recruiting status (3 now recruiting)
Show 3 sites
  • Psychiatrische Dienste Aargau (PDAG) · Windisch, Switzerlandno status→Recruiting
  • Eastern Switzerland University of Applied Sciences (OST) · Sankt Gallen, Switzerlandno status→Recruiting
  • Integrierte Psychiatrie Winterthur (ipw) · Winterthur, Switzerlandno status→Recruiting
Nov 10, 2026
Primary completion
Jun 2027→Oct 2027
Nov 10, 2026
Study completion
Jun 2027→Oct 2027
Nov 10, 2026
Contact
Study contact changed: j•••@ost.ch · •••3299→j•••@ost.ch · •••3299. See the current contact
Nov 10, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Eastern Switzerland University of Applied Sciences (OST) · Sankt Gallen, SwitzerlandContact j•••@ost.ch · •••3299→j•••@ost.ch · •••3299
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Not yet recruiting→Recruiting
    3 sites changed recruiting status (3 now recruiting)
    Show 3 sites
    • Psychiatrische Dienste Aargau (PDAG) · Windisch, Switzerlandno status→Recruiting
    • Eastern Switzerland University of Applied Sciences (OST) · Sankt Gallen, Switzerlandno status→Recruiting
    • Integrierte Psychiatrie Winterthur (ipw) · Winterthur, Switzerlandno status→Recruiting
    Primary completion Jun 2027→Oct 2027
    Study completion Jun 2027→Oct 2027
    Contact Study contact changed: j•••@ost.ch · •••3299→j•••@ost.ch · •••3299. See the current contact
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Eastern Switzerland University of Applied Sciences (OST) · Sankt Gallen, SwitzerlandContact j•••@ost.ch · •••3299→j•••@ost.ch · •••3299
    + 2 other changes: verification date and responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07766265
Lead sponsor
St.Gallen University of Applied Sciences
Collaborators
Swiss National Science Foundation
Responsible party
Joelle Albrecht (Principle Investigator, St.Gallen University of Applied Sciences) — Principal investigator
First posted
Aug 14, 2026
Start date
Aug 1, 2026
Primary completion
Oct 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Nov 10, 2026

Study contacts

Joelle Albrecht, MSc
Contact
joelle.albrecht@ost.ch
+41 58 257 32 99
Rahel Bachem, PhD
Contact
rahel.bachem@ost.ch
+41 58 257 35 26
Rahel Bachem, PhD
study chair · Eastern Switzerland University of Applied Sciences
Joelle Schenkel, MSc
principal investigator · Eastern Switzerland University of Applied Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion